BioSpace News Archive

Deals

Cerecor Enters Into $35 Million Debt Financing Agreement With Horizon Technology Finance

Cerecor Inc., a biopharmaceutical company focused on becoming a leader in the development and commercialization of treatments for rare and orphan diseases, announced that it has entered into a debt financing agreement led by Horizon Technology Finance Corporation to provide up to $35.0 million in term loans.

June 7, 2021
·
6 min read
Drug Development

BeyondSpring Announces Three Presentations Highlighting Positive Clinical Outcome Data from the Phase 3 Program of Plinabulin in Combination with Pegfilgrastim for the Prevention of Chemotherapy-Induced Neutropenia at the ASCO Annual Meeting

Data demonstrate that combination of plinabulin and pegfilgrastim offers superior benefit for reducing the incidence and severity of febrile neutropenia (FN) and hospitalization, with better quality-of-life (QoL), compared to pegfilgrastim alone

June 7, 2021
·
9 min read
MediWound Announces Peer-Reviewed Paper of a Case Series Report of Basal Cell Carcinoma Published in the Open Dermatology Journal

MediWound Ltd., a fully-integrated biopharmaceutical company focused on next-generation bio-therapeutic solutions for tissue repair and regeneration, announced that a peer-reviewed publication of a case series report of basal cell carcinoma destruction by a concentrate of proteolytic enzymes enriched in bromelain has been published in the Open Dermatology Journal.

June 7, 2021
·
7 min read
Business

4D Molecular Therapeutics Appoints Carolyne Zimmermann as Chief Business Officer

4D Molecular Therapeutics, a clinical-stage gene therapy company harnessing the power of directed evolution for targeted gene therapies, announced the appointment of Carolyne Zimmermann as Chief Business Officer.

June 7, 2021
·
3 min read
Drug Development

IN8bio Completes Treatment of First Cohort in Phase 1 Clinical Trial with Gamma Delta T-Cell Therapy in Patients with Newly Diagnosed Glioblastoma Multiforme

Single-dose administration of IN8bio’s genetically modified gamma delta T-cells in lymphodepleted glioblastoma multiforme (GBM) patients was well tolerated

June 7, 2021
·
7 min read
Biotech Bay

CareDx Presents Landmark KOAR-1000 Data, Demonstrating Higher 1-Year Graft Survival and Reduction in Biopsies through ARTS SurveillanceKOAR is the largest prospective validation study on AlloSure surveillance with over 1,500 patients enrolled

CareDx, Inc. announced an analysis of one-year data from the first 1000 patients enrolled in the Kidney Outcomes with AlloSure Registry will be presented at the American Transplant Congress 2021, which is taking place between June 4-9, 2021.

June 7, 2021
·
2 min read
Policy

Celltrion Healthcare launches Remsima™ SC, the world’s first subcutaneous formulation of infliximab in Canada, for the treatment of people with rheumatoid arthritis

Celltrion Healthcare Canada Limited announced the launch of Remsima™ SC, the world’s first subcutaneous formulation of infliximab in Canada for the treatment of adult patients with rheumatoid arthritis.

June 7, 2021
·
5 min read
Pharm Country

The University of Sydney secured a AU$1.4M grant plus AU$2M from industry and partners with Allelica, Inc. to advance heart disease prevention strategies through Polygenic Risk Score application

Professor Gemma Figtree at The University of Sydney and her multi-disciplinary team have been awarded AU$1.4 million by the National Health and Medical Research Council (NHMRC) Partnership Projects as part of a collaborative effort between academics and policy makers in Australia .

June 7, 2021
·
3 min read
Drug Development

RedHill Biopharma Completes Enrollment of Oral Opaganib Phase 2/3 COVID-19 Study

The global Phase 2/3 study of orally-administered opaganib for the treatment of severe COVID-19 enrolled a total of 475 patients, more than the planned 464

June 7, 2021
·
10 min read
Biotech Bay

Autobahn Labs Incubator Announces Partnership With Cold Spring Harbor Laboratory To Advance Novel Science To The Clinic

Autobahn Labs, an early-stage drug discovery incubator, announced a new strategic venture collaboration with Cold Spring Harbor Laboratory.

June 7, 2021
·
3 min read